Serum VEGF-D and VEGFR-3 are biomarkers in lymphangioleiomyomatosis for its diagnosis and impaired pulmonary function Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011
Maximally attained level of FEV1 and FEV1 decline determine airway hyperresponsiveness in adults Source: Eur Respir J 2003; 22: Suppl. 45, 17s Year: 2003
A tentative predictive score of rapid FEV1 decline in pulmonary lymphangioleiomyomatosis Source: Eur Respir J 2001; 18: Suppl. 33, 511s Year: 2001
Raised FeNO is associated with lower FEV1 and FEV1/FVC in children with asthma Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics Year: 2019
Serum levels of microRNA-125a are decreased in patients with precapillary pulmonary hypertension and correlate inversely with hemodynamics Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013
Methacholine challenge induced dyspnoea scores correlate with impulse oscillometry measured airway resistance but not spirometry Source: Eur Respir J 2004; 24: Suppl. 48, 340s Year: 2004
Comparison of FEV1 and mid flow parameters as markers of bronchial hyper responsiveness to methacholine Source: Eur Respir J 2003; 22: Suppl. 45, 276s Year: 2003
How to interpret reduced forced expiratory volume in 1 s (FEV1)/vital capacity ratio with normal FEV1 Source: Eur Respir J 2009; 33: 1396-1402 Year: 2009
Airway hyperresponsiveness, but not exhaled nitric oxide, as a risk factor for decline in post-bronchodilator FEV1 in patients with stable asthma Source: Annual Congress 2008 - Risk factors for allergic asthma and allergic rhinitis Year: 2008
Bronchial hyperreactivity (BHR) in sarcoidosis patients in correlation with airflow limitation indices Source: Eur Respir J 2006; 28: Suppl. 50, 204s Year: 2006
Estrogen receptor 1 polymorphisms are associated with bronchial hyperresponsiveness and FEV1 decline, particularly in female asthmatics Source: Eur Respir J 2005; 26: Suppl. 49, 3s Year: 2005
sGaw as an alternative for FEV1 in the measurement of airway responsiveness to methacholine in patients experiencing chronic cough Source: Annual Congress 2011 - Lung function today and tomorrow I Year: 2011
The influence of FVC manoeuvres on consecutive FEV1 values during methacholine challenge Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004
EXACT-PRO correlates with FEV1 and systemic inflammation but not airway inflammation Source: International Congress 2019 – Clinical implications of COPD management Year: 2019
Post-bronchodilator changes in volumes and airway caliber according to Peak flow and FEV1 reversibility Source: International Congress 2019 – New developments in sleep-disordered breathing, gas exchange and lung function in children Year: 2019
Dissociation between airway responsiveness to methacholine and responsiveness to antigen Source: Eur Respir J 2002; 19: 76-83 Year: 2002
FEV1 decline and eosinophilia in occupational asthma Source: Annual Congress 2011 - The work environment in the clinic Year: 2011
Methacholine challenges for detection of bronchial hyperresponsiveness (BHR) – a comparison of forced spirometry and body plethysmography Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment Year: 2009
Midflows do not vary independently of FEV1 and FVC Source: Annual Congress 2010 - Quality measurement and improvement in lung function Year: 2010